The properties of bone marrow-derived multipotent mesenchymal stromal cells (MSC) of patients with aplastic anemia at the onset of the disease are studied insufficiently. The aim of this work was to test the ability of MSC from patients with aplastic anemia to maintain hematopoietic precursors and to analyze the expression of genes associated with hematopoiesis and immune response. The ability of MSC to maintain hematopoietic precursors was determined by counting cobblestone area-forming cells; gene expression was analyzed by quantitative PCR. It was shown that MSC of patients with aplastic anemia preserve their ability to maintain hematopoietic precursors. Pronounced changes in the expression of the VEGFA and ANGPT1 genes were found. MSC from aplastic anemia patients with PNH clone significantly differ from those from aplastic anemia patients without PNH clone in terms of the expression of the SDF1, IL1R, and VEGFA genes. Changes in gene expression can be associated with the pathogenesis of the disease.
Similar content being viewed by others
References
Mihailova EA, Fidarova ZT, Troitskaya VV, Klyasova GA, Kulagin AD, Voronova EV, Dvirnyk VN, Galtseva IV, Kovrigina AM, Obukhova TN, Gapanova TV, Parovichnikova EN, Savchenko VG. Clinical recommendations for the diagnosis and treatment of aplastic anemia (2019 edition). Gematol. Transfusiol. 2020;65(2):208-226. doi: https://doi.org/10.35754/0234-5730-2020-65-2-208-226
Sorokina TV, Shipunova IN, Bigildeev AE, Drize NI, Kuzmina LA, Parovichnikova EN, Savchenko VG. Modification of gene expression in mesenchymal stromal cells of the acute myeloid leukemia patients during chemotherapy. Gematol. Transfusiol. 2016;61(3):126-133. doi: https://doi.org/10.18821/0234-5730/2016-61-3-126-133
Fidarova ZT, Abramova AV, Luchkin AV. Clone of paroxysmal nocturnal haemoglobinuria and other predictors of the response to immunosuppressive therapy in patients with idiopathic aplastic anaemia. Gematol. Transfusiol. 2019;64(3):342-352. doi: https://doi.org/10.35754/0234-5730-2019-64-3-342-352
Agarwal P, Isringhausen S, Li H, Paterson AJ, He J, Gomariz Á, Nagasawa T, Nombela-Arrieta C, Bhatia R. Mesenchymal niche-specific expression of Cxcl12 controls quiescence of treatment-resistant leukemia stem cells. Cell Stem Cell. 2019;24(5):769-784.e6. doi: https://doi.org/10.1016/j.stem.2019.02.018
Bigildeev AE, Zhironkina OA, Lubkova ON, Drize NJ. Interleukin- 1 beta is an irradiation-induced stromal growth factor. Cytokine. 2013;64(1):131-137. doi: https://doi.org/10.1016/j.cyto.2013.07.003
Blank U, Karlsson S. TGF-β signaling in the control of hematopoietic stem cells. Blood. 2015;125(23):3542-3550. doi: https://doi.org/10.1182/blood-2014-12-618090
Kuzmina LA, Petinati NA, Parovichnikova EN, Lubimova LS, Gribanova EO, Gaponova TV, Shipounova IN, Zhironkina OA, Bigildeev AE, Svinareva DA, Drize NJ, Savchenko VG. Multipotent mesenchymal stromal cells for the prophylaxis of acute graft-versus-host disease — a Phase II Study. Stem Cells Int. 2012;2012:968213. doi: https://doi.org/10.1155/2012/968213
Luzzatto L, Risitano AM. Advances in understanding the pathogenesis of acquired aplastic anaemia. Br. J. Haematol. 2018;182(6):758-776. doi: https://doi.org/10.1111/bjh.15443
Maciejewski JP, Selleri C, Sato T, Anderson S, Young NS. A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. Blood. 1996;88(6):1983-1991.
Manier S, Sacco A, Leleu X, Ghobrial IM, Roccaro AM. Bone marrow microenvironment in multiple myeloma progression. J. Biomed. Biotechnol. 2012;2012:157496. doi: https://doi.org/10.1155/2012/157496
Medyouf H. The microenvironment in human myeloid malignancies: emerging concepts and therapeutic implications. Blood. 2017;129(12):1617-1626. doi: https://doi.org/10.1182/blood-2016-11-696070
Ploemacher RE, van der Sluijs JP, van Beurden CA, Baert MR, Chan PL. Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming hematopoietic stem cells in the mouse. Blood. 1991;78(10):2527-2533.
Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008;3(6):1101-1108. doi: https://doi.org/10.1038/nprot.2008.73
Shipounova IN, Petrova TV, Svinareva DA, Momotuk KS, Mikhailova EA, Drize NI. Alterations in hematopoietic microenvironment in patients with aplastic anemia. Clin. Transl. Sci. 2009;2(1):67-74. doi: https://doi.org/10.1111/j.1752-8062.2008.00074.x
Somasundaram V, Tevatia M.S, Purohit A, Ahuja A, Mahapatra M, Tyagi S, Pati H, Saxena R. Evaluation of bone marrow microvessel density in patients with aplastic anemia. Indian J. Hematol. Blood Transfus. 2017;33(2):169-174. doi: https://doi.org/10.1007/s12288-016-0707-6
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Kletochnye Tekhnologii v Biologii i Meditsine, No. 4, pp. 233-237, December, 2021
Rights and permissions
About this article
Cite this article
Dorofeeva, A.I., Shipunova, I.N., Drize, N.I. et al. Bone Marrow Multipotent Mesenchymal Stromal Cells from Patients with Aplastic Anemia Retain Their Ability to Support Hematopoietic Precursors despite Pronounced Changes in Gene Expression. Bull Exp Biol Med 172, 637–641 (2022). https://doi.org/10.1007/s10517-022-05453-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-022-05453-y